163 related articles for article (PubMed ID: 32813034)
1. Cardiac serum marker alterations after intraoperative radiotherapy with low-energy x-rays in early breast cancer as an indicator of possible cardiac toxicity.
Stefanovic S; Berlit S; Sperk E; Wenz F; Weiß C; Trinkmann F; Sütterlin M; Tuschy B
Strahlenther Onkol; 2021 Jan; 197(1):39-47. PubMed ID: 32813034
[TBL] [Abstract][Full Text] [Related]
2. Long-term toxicity of an intraoperative radiotherapy boost using low energy X-rays during breast-conserving surgery.
Kraus-Tiefenbacher U; Bauer L; Scheda A; Fleckenstein K; Keller A; Herskind C; Steil V; Melchert F; Wenz F
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):377-81. PubMed ID: 16887294
[TBL] [Abstract][Full Text] [Related]
3. Role of Troponins I and T and N-Terminal Prohormone of Brain Natriuretic Peptide in Monitoring Cardiac Safety of Patients With Early-Stage Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Receiving Trastuzumab: A Herceptin Adjuvant Study Cardiac Marker Substudy.
Zardavas D; Suter TM; Van Veldhuisen DJ; Steinseifer J; Noe J; Lauer S; Al-Sakaff N; Piccart-Gebhart MJ; de Azambuja E
J Clin Oncol; 2017 Mar; 35(8):878-884. PubMed ID: 28199174
[TBL] [Abstract][Full Text] [Related]
4. Cosmetic Outcome and Chronic Breast Toxicity After Intraoperative Radiation Therapy (IORT) as a Single Modality or as a Boost Using the Intrabeam
Key S; Miglierini P; Dupré PF; Guilbert S; Lucia AS; Abgral R; Conan-Charlet V; Uguen A; Pradier O; Schick U
Ann Surg Oncol; 2017 Sep; 24(9):2547-2555. PubMed ID: 28608120
[TBL] [Abstract][Full Text] [Related]
5. N-terminal pro-B-type natriuretic peptide plasma levels as a potential biomarker for cardiac damage after radiotherapy in patients with left-sided breast cancer.
D'Errico MP; Grimaldi L; Petruzzelli MF; Gianicolo EA; Tramacere F; Monetti A; Placella R; Pili G; Andreassi MG; Sicari R; Picano E; Portaluri M
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e239-46. PubMed ID: 21640499
[TBL] [Abstract][Full Text] [Related]
6. A phase II study investigating the acute toxicity of targeted intraoperative radiotherapy as tumor-bed boost plus whole breast irradiation after breast-conserving surgery in Korean patients.
Ahn SG; Bae SJ; Lee HW; Yoon CI; Kim JW; Lee IJ; Jeong J
Breast Cancer Res Treat; 2019 Feb; 174(1):157-163. PubMed ID: 30467660
[TBL] [Abstract][Full Text] [Related]
7. Intraoperative radiotherapy (IORT) as a boost in patients with early-stage breast cancer -- acute toxicity.
Kraus-Tiefenbacher U; Bauer L; Kehrer T; Hermann B; Melchert F; Wenz F
Onkologie; 2006 Mar; 29(3):77-82. PubMed ID: 16514267
[TBL] [Abstract][Full Text] [Related]
8. Markers of Cardiotoxicity in Early Breast Cancer Patients Treated With a Hypofractionated Schedule: A Prospective Study.
De Sanctis V; Alfò M; Vitiello C; Vullo G; Facondo G; Marinelli L; Burocchi S; Gallo G; Valeriani M; Campanella B; Scalabrino G; Russo I; Salerno G; Cardelli P; Osti MF; De Biase L
Clin Breast Cancer; 2021 Jun; 21(3):e141-e149. PubMed ID: 33012660
[TBL] [Abstract][Full Text] [Related]
9. Intraoperative radiotherapy (IORT) of early breast cancer with low-energy x-rays in breast-conserving surgery : Prospective identification of pre- and intraoperative factors influencing the feasibility of IORT.
Grimm A; Wollmann E; Sperk E; Weiß C; Sütterlin M; Berlit S; Tuschy B
Strahlenther Onkol; 2024 Apr; 200(4):296-305. PubMed ID: 37792017
[TBL] [Abstract][Full Text] [Related]
10. Major complications after intraoperative radiotherapy with low-energy x-rays in early breast cancer.
Berger L; Grimm A; Sütterlin M; Spaich S; Sperk E; Tuschy B; Berlit S
Strahlenther Onkol; 2024 Apr; 200(4):276-286. PubMed ID: 37591980
[TBL] [Abstract][Full Text] [Related]
11. Exploratory analysis of cardiac biomarkers in women with normal cardiac function receiving trastuzumab for breast cancer.
Goel S; Simes RJ; Beith JM
Asia Pac J Clin Oncol; 2011 Sep; 7(3):276-80. PubMed ID: 21884439
[TBL] [Abstract][Full Text] [Related]
12. Early initiation of external beam radiotherapy (EBRT) may increase the risk of long-term toxicity in patients undergoing intraoperative radiotherapy (IORT) as a boost for breast cancer.
Wenz F; Welzel G; Keller A; Blank E; Vorodi F; Herskind C; Tomé O; Sütterlin M; Kraus-Tiefenbacher U
Breast; 2008 Dec; 17(6):617-22. PubMed ID: 18650091
[TBL] [Abstract][Full Text] [Related]
13. Intraoperative radiotherapy as a boost during breast-conserving surgery using low-kilovoltage X-rays: the first 5 years of experience with a novel approach.
Wenz F; Welzel G; Blank E; Hermann B; Steil V; Sütterlin M; Kraus-Tiefenbacher U
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1309-14. PubMed ID: 20100643
[TBL] [Abstract][Full Text] [Related]
14. A prospective phase I comparison of toxicity and cosmesis outcomes of single-fraction IORT and hypofractionated radiotherapy with IORT boost in early-stage breast cancer.
Bhandari T; Babaran W; Forouzannia A; Williams V; Harness J; Carpenter M; Gobran M; Khanijou R; Wagman B; Ash R; Wagman LD
Brachytherapy; 2017; 16(6):1232-1238.e2. PubMed ID: 29032999
[TBL] [Abstract][Full Text] [Related]
15. Troponin T-release associates with cardiac radiation doses during adjuvant left-sided breast cancer radiotherapy.
Skyttä T; Tuohinen S; Boman E; Virtanen V; Raatikainen P; Kellokumpu-Lehtinen PL
Radiat Oncol; 2015 Jul; 10():141. PubMed ID: 26159409
[TBL] [Abstract][Full Text] [Related]
16. Intraoperative radiotherapy in women with early breast cancer treated by breast-conserving therapy.
Chua BH; Henderson MA; Milner AD
ANZ J Surg; 2011 Jan; 81(1-2):65-9. PubMed ID: 21299801
[TBL] [Abstract][Full Text] [Related]
17. The TARGIT trial: targeted intraoperative radiation therapy versus conventional postoperative whole-breast radiotherapy after breast-conserving surgery for the management of early-stage invasive breast cancer (a trial update).
Holmes DR; Baum M; Joseph D
Am J Surg; 2007 Oct; 194(4):507-10. PubMed ID: 17826067
[TBL] [Abstract][Full Text] [Related]
18. [The role of biochemical markers with special regard to troponin, CK-MB, NT-proBNP as early biomarkers of cardiotoxicity among women after chemotherapy due to breast cancer].
Stachowiak P; Milchert-Leszczyńska M; Falco M; Polakowska M; Wojtarowicz A; Kaliszczak R; Safranow K; Kornacewicz-Jach Z
Przegl Lek; 2016; 73(6):359-63. PubMed ID: 29668198
[TBL] [Abstract][Full Text] [Related]
19. Redefining Eligibility by Analyzing Canceled Intraoperative Radiotherapy as a Boost for Patients Undergoing Breast-Conserving Treatment.
Kim JW; Cho Y; Choi J; Ahn SG; Jeong J; Lee IJ
Ann Surg Oncol; 2019 Dec; 26(13):4294-4301. PubMed ID: 31520209
[TBL] [Abstract][Full Text] [Related]
20. Postoperative seroma formation after intraoperative radiotherapy using low-kilovoltage X-rays given during breast-conserving surgery.
Kraus-Tiefenbacher U; Welzel G; Brade J; Hermann B; Siebenlist K; Wasser KS; Schneider FS; Sütterlin M; Wenz F
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1140-5. PubMed ID: 19836152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
